If you made any changes in Pure these will be visible here soon.

Research Output 1997 2020

Filter
Article
2020

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M. G., Dotti, K. F., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., De Placido, S., Frassineti, G. L., Ciarlo, A. & 11 others, Buonadonna, A., Silvestris, N., Piazza, E., Pavesi, L., Moroni, M., Clerico, M., Aglietta, M., Giordani, P., Galli, F., Galli, F. & Petrelli, F., Jan 1 2020, In : Therapeutic Advances in Medical Oncology. 12

Research output: Contribution to journalArticle

Open Access
Colorectal Neoplasms
Adjuvant Chemotherapy
Confidence Intervals
Logistic Models
Survival

Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis

on behalf of TOSCA (Three or Six Colon Adjuvant) Investigators, Jan 1 2020, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Colonic Neoplasms
oxaliplatin
Mucinous Adenocarcinoma
Neoplasms
Adjuvant Chemotherapy
2019

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

Auclin, E., André, T., Taieb, J., Banzi, M., Van Laethem, J. L., Tabernero, J., Hickish, T., de Gramont, A. & Vernerey, D., Jan 1 2019, In : British Journal of Cancer.

Research output: Contribution to journalArticle

oxaliplatin
Carcinoembryonic Antigen
Colonic Neoplasms
Survival
Disease-Free Survival

Carcinoembryonic antigen levels and survival in stage III colon cancer: Post hoc analysis of the MOSAIC and PETACC-8 trials

Auclin, E., Taieb, J., Lepage, C., Aparicio, T., Faroux, R., Mini, E., Folprecht, G., Salazar, R., Benetkiewicz, M., Banzi, M., Louvet, C., Van Laethem, J. L., Tabernero, J., Hickish, T., De Gramont, A., Andre, T. & Vernerey, D., Jan 1 2019, In : Cancer Epidemiology Biomarkers and Prevention. 28, 7, p. 1153-1161 9 p.

Research output: Contribution to journalArticle

Carcinoembryonic Antigen
Colonic Neoplasms
Survival
Disease-Free Survival
Proportional Hazards Models

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Investigators, TOSCA. T. O. S. C. A., Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L. & 20 others, Tronconi, M. C., Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F. & Di Bartolomeo, M., Mar 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

oxaliplatin
Metformin
Colonic Neoplasms
Drug Therapy
Survival

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

TOSCA (Three or Six Colon Adjuvant) Investigators, Mar 2019, In : The oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

oxaliplatin
Metformin
Colonic Neoplasms
Drug Therapy
Survival

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 20 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F., Di Bartolomeo, M. & Investigators, TOSCA. T. O. S. C. A., Mar 2019, In : The oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

oxaliplatin
Metformin
Colonic Neoplasms
Drug Therapy
Survival

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 18 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F. & Di Bartolomeo, M., 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 20 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F., Di Bartolomeo, M. & Investigators, TOSCA. T. O. S. C. A., Mar 1 2019, In : The oncologist. 24, p. 385-393 9 p.

Research output: Contribution to journalArticle

The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study

Iachetta, F., Bonelli, C., Romagnani, A., Zamponi, R., Tofani, L., Farnetti, E., Nicoli, D., Damato, A., Banzi, M., Casali, B. & Pinto, C., Apr 16 2019, In : British Journal of Cancer. 120, 8, p. 834-839 6 p.

Research output: Contribution to journalArticle

Single Nucleotide Polymorphism
Case-Control Studies
Drug Therapy
Neutropenia
Fluorouracil
Colonic Neoplasms
Neoplasms
Therapeutics
Survival
Disease-Free Survival
2018

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

on behalf of the TOSCA Investigators, May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin
oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Investigators, O. B. O. T. TOSCA., Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S. & 2 others, Rulli, E. & Labianca, R., May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S., Rulli, E. & 1 others, Labianca, R., 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the italian three or six colon adjuvant trial

Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S., Rulli, E. & 1 others, Labianca, R., 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

Investigators, TOSCA., Sobrero, A., Lonardi, S., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Pella, N., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Zagonel, V., Maiello, E., Barni, S. & 2 others, Rulli, E. & Labianca, R., May 20 2018, In : Journal of Clinical Oncology. 36, 15, p. 1478-1485 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Colonic Neoplasms
Colon
Recurrence
Leucovorin

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J-F., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R. D., Maiello, E., André, T., Spallanzani, A., Garcia-Carbonero, R., Arriaga, Y. E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A. & 3 others, Kalmus, J., Falcone, A. & Zaniboni, A., Sep 6 2018, In : The oncologist.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Disease-Free Survival
Safety
regorafenib

Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study

Van Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J. F., Barone, C., Ychou, M., Peeters, M., Brenner, B., Hofheinz, R. D., Maiello, E., André, T., Spallanzani, A., Garcia-Carbonero, R., Arriaga, Y. E., Verma, U., Grothey, A., Kappeler, C., Miriyala, A. & 3 others, Kalmus, J., Falcone, A. & Zaniboni, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Therapeutics
Disease-Free Survival
Safety
regorafenib
2017

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Massida, B., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E. & 3 others, Rulli, E., Labianca, R. & TOSCA (Three or Six Colon Adjuvant) Investigators, Feb 23 2017, In : Annals of Oncology.

Research output: Contribution to journalArticle

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Marmorino, F., Salvatore, L., Barbara, C., Allegrini, G., Antonuzzo, L., Masi, G., Loupakis, F., Borelli, B., Chiara, S., Banzi, M. C., Miraglio, E., Amoroso, D., Dargenio, F., Bonetti, A., Martignetti, A., Paris, M., Tomcikova, D., Boni, L., Falcone, A. & Cremolini, C., Jan 2017, In : British Journal of Cancer. 116, 3, p. 318-323 6 p.

Research output: Contribution to journalArticle

L-Lactate Dehydrogenase
Colorectal Neoplasms
Serum
Angiogenesis Inhibitors
Therapeutics

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Marmorino, F., Salvatore, L., Barbara, C., Allegrini, G., Antonuzzo, L., Masi, G., Loupakis, F., Borelli, B., Chiara, S., Banzi, M. C., Miraglio, E., Amoroso, D., Dargenio, F., Bonetti, A., Martignetti, A., Paris, M., Tomcikova, D., Boni, L., Falcone, A. & Cremolini, C., 2017, In : British Journal of Cancer. 116, 3, p. 318-323 6 p.

Research output: Contribution to journalArticle

L-Lactate Dehydrogenase
Colorectal Neoplasms
Serum
Angiogenesis Inhibitors
Therapeutics

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Marmorino, F., Salvatore, L., Barbara, C., Allegrini, G., Antonuzzo, L., Masi, G., Loupakis, F., Borelli, B., Chiara, S., Banzi, M. C., Miraglio, E., Amoroso, D., Dargenio, F., Bonetti, A., Martignetti, A., Paris, M., Tomcikova, D., Boni, L., Falcone, A. & Cremolini, C., Jan 2017, In : British Journal of Cancer. 116, 3, p. 318-323 6 p.

Research output: Contribution to journalArticle

L-Lactate Dehydrogenase
Colorectal Neoplasms
Serum
Angiogenesis Inhibitors
Therapeutics

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer

Marmorino, F., Salvatore, L., Barbara, C., Allegrini, G., Antonuzzo, L., Masi, G., Loupakis, F., Borelli, B., Chiara, S., Banzi, M. C., Miraglio, E., Amoroso, D., Dargenio, F., Bonetti, A., Martignetti, A., Paris, M. K., Tomcikova, D., Boni, L., Falcone, A. & Cremolini, C., Jan 1 2017, In : British Journal of Cancer. 116, 3, p. 318-323 6 p.

Research output: Contribution to journalArticle

L-Lactate Dehydrogenase
Colorectal Neoplasms
Serum
Angiogenesis Inhibitors
Therapeutics
2016

Dabrafenib: A new opportunity for the treatment of BRAFV600-positive melanoma

Banzi, M., de Blasio, S., Lallas, A., Longo, C., Moscarella, E., Alfano, R. & Argenziano, G., May 6 2016, In : OncoTargets and Therapy. 9, p. 2725-2733 9 p.

Research output: Contribution to journalArticle

Melanoma
Survival
Mitogen-Activated Protein Kinases
Epidemiology
Therapeutics

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 2 others, Labianca, R. & Investigators, TOSCA. T. O. S. C. A., Nov 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
oxaliplatin
Therapeutics
Adjuvant Chemotherapy
XELOX

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 2 others, Labianca, R. & TOSCA (Three or Six Colon Adjuvant) Investigators, Nov 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Compliance
Safety
oxaliplatin
Therapeutics

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 1 others, Labianca, R., 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 1 others, Labianca, R., 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

Lonardi, S., Sobrero, A., Rosati, G., Di Bartolomeo, M., Ronzoni, M., Aprile, G., Scartozzi, M., Banzi, M., Zampino, M. G., Pasini, F., Marchetti, P., Cantore, M., Zaniboni, A., Rimassa, L., Ciuffreda, L., Ferrari, D., Barni, S., Zagonel, V., Maiello, E., Rulli, E. & 1 others, Labianca, R., 2016, In : Annals of Oncology. 27, 11, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Colonic Neoplasms
Compliance
Safety
oxaliplatin
Therapeutics
2015

Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: Updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study

André, T., De Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., Banzi, M., Maartense, E., Shmueli, E., Carlsson, G. U., Scheithauer, W., Papamichael, D., Möehler, M., Landolfi, S., Demetter, P., Colote, S. & 5 others, Tournigand, C., Louvet, C., Duval, A., Fléjou, J. F. & De Gramont, A., Dec 10 2015, In : Journal of Clinical Oncology. 33, 35, p. 4176-4187 12 p.

Research output: Contribution to journalArticle

oxaliplatin
DNA Mismatch Repair
Leucovorin
Fluorouracil
Colonic Neoplasms

A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases

Zalaudek, I., Ciarrocchi, A., Piana, S., Argenziano, G., Torricelli, F., Sancisi, V., Gandolfi, G., Longo, C., Moscarella, E., Banzi, C. & Nicoli, D., Feb 1 2015, In : Journal of the European Academy of Dermatology and Venereology. 29, 2, p. 387-390 4 p.

Research output: Contribution to journalArticle

Amelanotic Melanoma
Neoplasm Metastasis
Mutation
Phenotype
Codon
2014
Mutation
Non-Small Cell Lung Carcinoma
Genes
Neoplasms
Exons
2013

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

Rimassa, L., Pressiani, T., Boni, C., Carnaghi, C., Rota Caremoli, E., Fagiuoli, S., Foa, P., Salvagni, S., Cortesi, E., Chiara Tronconi, M., Personeni, N., Bozzarelli, S., Chiara Banzi, M., Fanello, S., Romano Lutman, F., Giordano, L. & Santoro, A., 2013, In : The oncologist. 18, 4, p. 379-380 2 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Arm
Disease-Free Survival
Disease Progression
Stomatitis
Dihydrouracil Dehydrogenase (NADP)
Appointments and Schedules
Fluorouracil
Dihydropyrimidine Dehydrogenase Deficiency
Tegafur

Sorafenib in patients with child-pugh class A and B advanced hepatocellular carcinoma: A prospective feasibility analysis

Pressiani, T., Boni, C., Rimassa, L., Labianca, R., Fagiuoli, S., Salvagni, S., Ferrari, D., Cortesi, E., Porta, C., Mucciarini, C., Latini, L., Carnaghi, C., Banzi, M., Fanello, S., De Giorgio, M., Lutman, F. R., Torzilli, G., Tommasini, M. A., Ceriani, R., Covini, G. & 5 others, Tronconi, M. C., Giordano, L., Locopo, N., Naimo, S. & Santoro, A., Feb 2013, In : Annals of Oncology. 24, 2, p. 406-411 6 p., mds343.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Survival
Liver
Disease-Free Survival
sorafenib
2012

Epidermal growth factor receptor (EGFR) gene copy number in colorectal adenoma-carcinoma progression

Flora, M., Piana, S., Bassano, C., Bisagni, A., De Marco, L., Ciarrocchi, A., Tagliavini, E., Gardini, G., Tamagnini, I., Banzi, C. & Bisagni, G., Dec 2012, In : Cancer genetics. 205, 12, p. 630-635 6 p.

Research output: Contribution to journalArticle

erbB-1 Genes
Gene Dosage
Epidermal Growth Factor Receptor
Adenoma
Colorectal Neoplasms
2009

Similarities and differences between the adjuvant oxaliplatin-based trials MOSAIC and NSABP C-07

Boni, C., André, T., Banzi, M. C., Hickish, T., Tabernero, J., Clingan, P., Chibaudel, B. & De Gramont, A., Jul 2009, In : Current Colorectal Cancer Reports. 5, 3, p. 166-170 5 p.

Research output: Contribution to journalArticle

oxaliplatin
Fluorouracil
Colonic Neoplasms
Diarrhea
Wounds and Injuries
2008

The role of cetuximab in pre-treated refractory patients with metastatic colorectal cancer: Outcome study in clinical practice

Lelli, G., Cataldo, S., Carandina, I., Urbini, B., Bonetti, F., Marzola, M., Biasco, G., Pantaleo, M. A., Brandes, A., Calandri, C., Ravaioli, E., Nanni, O., Boni, C., Banzi, C., Negri, F., Panetta, A., Di Fabio, F. & Turci, D., Jun 2008, In : Journal of Chemotherapy. 20, 3, p. 374-379 6 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Outcome Assessment (Health Care)
Weight Loss
irinotecan
Survival
2005

Erratum: Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer (British Journal of Cancer (2004) 92 (24-29) DOI: 10.1038/sj.bjc.6602276)

Sobrero, A., Frassineti, G., Falcone, A., Dogliotti, L., Rosso, R., Di Costanzo, F., Bruzzi, P., Comandone, A., Bumma, C., Mestriner, M., Faggiuolo, R., Nanni, O., Amadori, D., Rosetti, P., Turci, D., Marangolo, M., Zumaglini, F., Boni, C., Bisagni, G., Banzi, M. & 66 others, Contu, A., Olmeo, N., Pazzola, A., Oliverio, G., Venturini, B., Gambi, A., Amaducci, L., Faedi, M., Marzola, M., Arcispedale, S., Anna-Ferrara, N. V., Biasco, G., Antini, M., Artioli, F., Cagossi, K., Gandini, G., Zuccarino, L., Recchia, F., Saggi, G., Cesta, A., Bravi, S., Biagioni, F., Acito, L., Giustini, L., Bascioni, R., Marzola, M., Lelli, G., Modonesi, C., Luppi, G., Zironi, S., Frassoldati, A., Ardizzoia, A., Barni, S., Leonardi, F., Pucci, F., Camisa, R., Tonato, M., Corgna, E., Rodino', C., Cavanna, L., Gasperoni, S., RosaBian, A., Bassan, F., Attardo, G., Cavalli, C., Olgiati, A., Conte, P., Pfanner, E., Brunetti, I., Lencioni, M., Campora, E., Gatti, C., Guarnieri, D., Gallo, L., Caroti, C., Mammoliti, S., Barsanti, G., Battistoni, M., Brema, F., Ospedale, S., Savona, P., Taviani, E., Galli, C., Francesconi, D., Spinelli, I. & Chiavistelli, P., Sep 19 2005, In : British Journal of Cancer. 93, 6, p. 733 1 p.

Research output: Contribution to journalArticle

2002

Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition

Rio, G. D., Zironi, S., Valeriani, L., Menozzi, R., Bondi, M., Bertolini, M., Piccinini, L., Banzi, M. C. & Federico, M., 2002, In : Breast Cancer Research and Treatment. 73, 3, p. 267-273 7 p.

Research output: Contribution to journalArticle

Body Composition
Methotrexate
Fluorouracil
Energy Metabolism
Weight Gain
2001

Oxaliplatino e cancro del colon-retto

Translated title of the contribution: Oxaliplatin and colorectal cancerBoni, C. & Banzi, M., 2001, In : Tumori. 87, 1 SUPPL. 1

Research output: Contribution to journalArticle

2000

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the italian oncology group for clinical research (GOIRC)

Boni, C., Bisagni, G., Savoldi, L., Moretti, G., Rondini, E., Sassi, M., Zadro, A., De Pas, T., Franciosi, V., Pazzola, A., Vignoli, R., Banzi, M. C. & Pajetta, V., 2000, In : International Journal of Cancer. 87, 5, p. 724-727 4 p.

Research output: Contribution to journalArticle

gemcitabine
Ifosfamide
Medical Oncology
Non-Small Cell Lung Carcinoma
Cisplatin
1997

Changes of biological features in breast cancer cells determined by primary chemotherapy

Frassoldati, A., Adami, F., Banzi, C., Criscuolo, M., Piccinini, L. & Silingardi, V., 1997, In : Breast Cancer Research and Treatment. 44, 3, p. 185-192 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Proliferating Cell Nuclear Antigen
Anthracyclines
Histology